Careteq (ASX:CTQ) ROE % Adjusted to Book Value: -18.29% (As of Dec. 2025)


What is Careteq ROE % Adjusted to Book Value?

Careteq ASX:CTQ ROE % Adjusted to Book Value is -18.29% as of Dec. 2025. The stock has 8 warning signs investors should review.

Careteq's ROE % for the quarter that ended in Dec. 2025 was -40.23%. Careteq's PB Ratio for the quarter that ended in Dec. 2025 was 2.20. Careteq's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -18.29%.

Careteq ROE % Adjusted to Book Value Related Terms

Careteq ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Careteq's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careteq ROE % Adjusted to Book Value Chart

Careteq Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
ROE % Adjusted to Book Value
0.00 -42.03 -50.31 -81.07 -2.25

Careteq Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only -41.06 -69.04 -8.24 6.92 -18.29

ASX:CTQ vs VEEV, BTSG, TEM: ROE % Adjusted to Book Value Comparison

For the Health Information Services subindustry, Careteq's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Careteq ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Careteq's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Careteq's ROE % Adjusted to Book Value falls into.


Careteq ROE % Adjusted to Book Value Calculation

Careteq's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4.12% / 1.83
=-2.25%

Careteq's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-40.23% / 2.20
=-18.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -18.29% mean?
Careteq (ASX:CTQ) has a ROE % Adjusted to Book Value of -18.29% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Careteq and its competitors.
Is Careteq's ROE % Adjusted to Book Value too high?
Careteq's current ROE % Adjusted to Book Value is -18.29%.
How does Careteq's ROE % Adjusted to Book Value compare to VEEV and BTSG?
Careteq's ROE % Adjusted to Book Value of -18.29% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Careteq and its competitors. Careteq's current ROE % Adjusted to Book Value is -18.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careteq stock overvalued right now?
Based on GuruFocus' analysis, Careteq (ASX:CTQ) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 20% above its estimated fair value. The current ROE % Adjusted to Book Value is -18.29%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Careteq (ASX:CTQ), the current ROE % Adjusted to Book Value is -18.29% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Careteq Business Description

Address 99 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuses on medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.